Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer
Clinical trial NCT05981014 · RECRUITING
Trial details
- NCT number
- NCT05981014
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-01
- Primary completion
- 2030-12-31
- Enrollment
- 196
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.